P2RX4 and myeloid sarcoma: In addition, the study of multi-incident MS families have nominated pathogenic mutations in NLRP1, and purinergic receptors P2RX4/P2RX7 which initiate inflammasome formation by modifying intracellular calcium and potassium concentrations [10, 11].